Healx Has Received Approval To Start Phase 2a Fragile X Syndrome Clinical Trial
Healx has just announced that they've been given Investigational New Drug FDA approval for HLX-0201 for Fragile X syndrome. This means they are able to move forward with their Phase 2a…